Bulk turalio
Ended Awarded Last action
- Contract number
- 36C26025F0129
- Awardee
-
Daiichi Sankyo, Inc. UEI YUKQY5G72Q29
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $48,124
Award facts
- Contract value 100% obligated
- $48,124.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cary, NC 27513, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$64,166 | |
| Original award | $112,290 |
About this award
Daiichi Sankyo, Inc. was awarded a delivery order valued at $48,124.16 by Veterans Integrated Service Network 20 (VISN 20), part of the Department of Veterans Affairs, on January 20, 2025. The contract, which carries a firm fixed-price structure with no set-aside designation, covers the supply of TURALIO (pexidartinib) pharmaceutical products for delivery to a location in Cary, North Carolina, with a completion deadline of September 30, 2025. This delivery order falls under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB), a governmentwide acquisition vehicle that streamlines federal procurement of pharmaceutical products.
TURALIO is a specialized medication used to treat tenosynovial giant cell tumor, a rare medical condition affecting veterans served by VISN 20. Daiichi Sankyo, Inc., a for-profit pharmaceutical manufacturer headquartered in Basking Ridge, New Jersey, has established itself as a key supplier of this specialized therapeutic to the VA through multiple delivery orders and a blanket purchase agreement. The company's federal contracting activity focuses exclusively on providing TURALIO in various dosage forms (125mg and 200mg capsules) to support the VA's mission of delivering targeted healthcare solutions to the veteran population.
Quick answers
Who was awarded contract 36C26025F0129?
36C26025F0129 was awarded to Daiichi Sankyo, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on January 20, 2025.
How much is contract 36C26025F0129 worth?
The government has obligated $48,124 on 36C26025F0129.
Is contract 36C26025F0129 an order under another contract?
Yes. 36C26025F0129 is a delivery order under 36F79718D0403, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26025F0129 competed?
The extent of competition for 36C26025F0129 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award